Linden Asset
Overview
Venture capital firm that focuses on growth-stage and Series B startups in the Asia Pacific region, particularly in the fields of biotechnology, medtech, high tech, and smart technology. It manages both US dollar- and RMB-denominated funds. As of December 2020, the firm had invested in 12 companies. Its portfolio includes companies that have had IPOs, such as Shanghai Henlius Biotech, PPDai, and Genor Biopharma.
Portfolio Companies
4
Website
lindenasset.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pulse Medical Imaging Technology | Aug 2021 | Series C | Co-investor |
| Creative Biosciences (Guangzhou) Co., Ltd. | Sep 2020 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Linden Asset based?
Linden Asset is headquartered in Shanghai, Shanghai, China.
When was Linden Asset founded?
Founding year information for Linden Asset is not publicly available.
How many portfolio companies does Linden Asset have?
Linden Asset has 4 portfolio companies in Caplight's dataset.
What are some companies in Linden Asset's portfolio?
Portfolio companies visible on Caplight include Pulse Medical Imaging Technology, Creative Biosciences (Guangzhou) Co., Ltd..
What was Linden Asset's most recent investment shown here?
Linden Asset's most recent investment in this portfolio sample was in Pulse Medical Imaging Technology in 2021.
What sectors does Linden Asset focus on?
Linden Asset focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, FinTech, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does Linden Asset focus on?
Linden Asset typically invests at the Mid stage.